Are you an endometriosis patient looking for a new treatment? Find the centres equipped with Winback technologies near you.

How does Winback tecartherapy fit into the treatment of endometriosis-related pain?

Discover how therapists are using Winback technologies to treat patients suffering from endometriosis, through clinical cases, various resources and testimonials.

Summary

A reminder about endometriosis

Endometriosis is defined as the presence of endometrial tissue outside the uterine cavity, which is affected by hormonal changes during each subsequent menstrual cycle. During menstruation, under the effect of uterine contractions, endometrial cells are regurgitated into the fallopian tubes and end up in the abdomino-pelvic cavity.

Instead of being eliminated by the immune system, these endometrial cells implant themselves and then, under the effect of subsequent hormonal stimulation, proliferate in neighbouring tissues and organs (peritoneum, ovary, fallopian tube, intestine, bladder, ureter, diaphragm, etc.). The organs are then infiltrated with endometrial tissue. There are therefore several forms of endometriosis: superficial (or peritoneal) endometriosis, ovarian endometriosis, deep pelvic endometriosis and extra-pelvic endometriosis.

Endometriosis is therefore responsible for disabling pelvic pain, dysmenorrhoea, dyspareunia, dysuria and even infertility, as well as physical deconditioning. These symptoms have a major impact on the quality of life of sufferers, with significant repercussions on their personal and conjugal lives, as well as their professional and social lives, constituting a real invisible handicap.[1] [2]

Endometriosis in a few figures

1 IN 10 WOMEN

Endometriosis affects around 1 in 10 women worldwide, making it a common but often under-diagnosed condition.[1]

7 TO 10 YEARS

On average, diagnosis is delayed for 7 to 10 years after the first symptoms appear, leading to prolonged suffering and potential complications.[1]

30% TO 40%​

Up to 30-40% of women with endometriosis may experience fertility problems.[1]

Tecartherapy

IN BRIEF

Non-invasive and painless, the Tecar high-frequency current provides membrane depolarisation over a frequency range of 300 kHz to 1 MHz, resulting in an increase in intra- and extra-cellular exchanges[3]. Winback tecartherapy enables the therapist to work on pain stimuli, their transmission and the fascias, thereby reducing pain and improving movement.

3 KEY THERAPEUTIC EFFECTS COMBINED

Thanks to saturation of nociceptors and inhibition of transmission

Stimulates cellular metabolism[4]

Improves tissue trophicity and viscoelasticity, promotes vascularisation

INDICATIONS

Extremely versatile, tecartherapy is indicated in many areas of rehabilitation, particularly in the post-partum period, but also in the case of acute and chronic pathologies that can occur at different times in a woman’s life.

traitement endométriose

The effect of tecar on endometriosis

The pelvic pain of endometriosis is linked to the loss of mobility caused by adhesions and a reduction in the sliding planes of the various tissues in the pelvic cavity and sometimes extra-pelvic. As this area is highly innervated (nociceptors, interoceptors), this nociceptive pain becomes chronic through central sensitisation. [5]

Tecartherapy will then :

*Only for Winback customers

*Only for Winback customers

Clinical cases

STUDY CASE: TREATMENT OF A PATIENT WITH ENDOMETRIOSIS

2. CASE STUDY OF A PATIENT WITH ADENOMYOSIS

REFERENCES AND BIBLIOGRAPHY :

[1] Qu’est ce que l’endométriose ? | Association EndoFrance. (s. d.). Association EndoFrance. See the source

[2] Shafrir AL, Farland LV, Shah DK, et al. . Risk for and consequences of endometriosis: a critical epidemiologic review. Best Pract Res Clin Obstet Gynaecol 2018; 51: 1–15. – See the source

[3] Bohnert J, Dössel O. Effects of time varying currents and magnetic fields in the frequency range of 1 kHz to 1 MHz to the human body-a simulation study. See the source

[4] Trillo MA, Martinez MA, Ubeda. Effects of the signal modulation on the response of human fibroblasts to in vitro stimulation with subthermal RF currents. See the source

[5] The Role of Interventional Pain Management Strategies for Neuropathic Pelvic Pain in Endometriosis. See the source

[6] Qu’est ce que l’adénomyose ? | Association EndoFrance. (s. d.). Association EndoFrance. See the source

Consult other resources addressing
in the perineopelvic sphere

It seems we can't find what you're looking for.

WOULD YOU LIKE TO LEARN MORE ABOUT WINBACK AND HOW TO INTEGRATE IT INTO THE TREATMENT OF YOUR PATIENTS WITH ENDOMETRIOSIS?

REQUEST TO BE CONTACTED BY AN EXPERT BY FILLING OUT THE FORM BELOW.

How can we help you today?(Required)
Name